Expert Interview
Digging into the recent data from the Phase 2 clinical trial of Lilly's muvalaplin in patients with elevated LPa.
Ticker(s): LLYInstitution: Comprehensive Internal Medicine & Cardiology Associates of Huntington
- Attending physician specializing in cardiology and affiliated with Huntington Hospital.
- Currently manages ~100 patients for elevated LPa.
- Very familiar with the Phase 2 clinical trial data of muvalaplin.
Roughly how many patients with elevated LPa do you manage monthly?
Added By: c_adminWhat are your thoughts on the P2 data on muvalaplin?
Added By: c_adminCan you comment on the concept that muvalaplin doesn’t destroy apo(a), just dissociates it from apo(b), and that free apo(a) could cause fibrin reactions or inflammation that leads to a differential outcome from apo(a) gene silencing drugs.
Added By: c_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
